A clinical study of pharyngeal small cell carcinoma

Fumihiro Ito, Hiroyuki Ozawa, Mariko Sekimizu, Yoshihiro Watanabe, Toshiki Tomita, Yorihisa Imanishi, Kaoru Ogawa

Research output: Contribution to journalArticle

Abstract

Extrapulmonary small cell carcinoma arising from the pharynx is rare. We have experienced 4 cases of pharyngeal small cell carcinoma. All the patients were male, and the mean age was 66 years old. The primary site was the oropharynx in 2 cases and the hypopharynx in 2 cases. All the patients initially underwent surgical resection, followed by chemotherapy or chemoradiotherapy. Three patients died because of distant metastasis. One patient is still alive without disease. Twentyfour cases of pharyngeal small cell carcinoma have been reported to date. An analysis of these 28 cases, including our 4 cases, revealed that 20 of the cases had died because of pharyngeal small cell carcinoma. Thus, pharyngeal small cell carcinoma appears to be associated with a relatively poor prognosis similar to that of pulmonary small cell carcinoma. Patients with T3/4 or metastatic diseases have an especially poor prognosis. When the primary site is resectable with minimum invasion, surgery followed by chemotherapy or chemoradiotherapy might offer a better chance of inhibiting local recurrence, compared with other strategies.

Original languageEnglish
Pages (from-to)825-832
Number of pages8
JournalJournal of Otolaryngology of Japan
Volume120
Issue number6
Publication statusPublished - 2017

Fingerprint

Small Cell Carcinoma
Chemoradiotherapy
Drug Therapy
Hypopharynx
Oropharynx
Pharynx
Clinical Studies
Neoplasm Metastasis
Recurrence
Lung

Keywords

  • Chemoradiotherapy
  • Pharyngeal cancer
  • Small cell carcinoma
  • Surgery

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Cite this

A clinical study of pharyngeal small cell carcinoma. / Ito, Fumihiro; Ozawa, Hiroyuki; Sekimizu, Mariko; Watanabe, Yoshihiro; Tomita, Toshiki; Imanishi, Yorihisa; Ogawa, Kaoru.

In: Journal of Otolaryngology of Japan, Vol. 120, No. 6, 2017, p. 825-832.

Research output: Contribution to journalArticle

Ito, F, Ozawa, H, Sekimizu, M, Watanabe, Y, Tomita, T, Imanishi, Y & Ogawa, K 2017, 'A clinical study of pharyngeal small cell carcinoma', Journal of Otolaryngology of Japan, vol. 120, no. 6, pp. 825-832.
Ito F, Ozawa H, Sekimizu M, Watanabe Y, Tomita T, Imanishi Y et al. A clinical study of pharyngeal small cell carcinoma. Journal of Otolaryngology of Japan. 2017;120(6):825-832.
Ito, Fumihiro ; Ozawa, Hiroyuki ; Sekimizu, Mariko ; Watanabe, Yoshihiro ; Tomita, Toshiki ; Imanishi, Yorihisa ; Ogawa, Kaoru. / A clinical study of pharyngeal small cell carcinoma. In: Journal of Otolaryngology of Japan. 2017 ; Vol. 120, No. 6. pp. 825-832.
@article{dadc804375a448b386a19bfe74798f1c,
title = "A clinical study of pharyngeal small cell carcinoma",
abstract = "Extrapulmonary small cell carcinoma arising from the pharynx is rare. We have experienced 4 cases of pharyngeal small cell carcinoma. All the patients were male, and the mean age was 66 years old. The primary site was the oropharynx in 2 cases and the hypopharynx in 2 cases. All the patients initially underwent surgical resection, followed by chemotherapy or chemoradiotherapy. Three patients died because of distant metastasis. One patient is still alive without disease. Twentyfour cases of pharyngeal small cell carcinoma have been reported to date. An analysis of these 28 cases, including our 4 cases, revealed that 20 of the cases had died because of pharyngeal small cell carcinoma. Thus, pharyngeal small cell carcinoma appears to be associated with a relatively poor prognosis similar to that of pulmonary small cell carcinoma. Patients with T3/4 or metastatic diseases have an especially poor prognosis. When the primary site is resectable with minimum invasion, surgery followed by chemotherapy or chemoradiotherapy might offer a better chance of inhibiting local recurrence, compared with other strategies.",
keywords = "Chemoradiotherapy, Pharyngeal cancer, Small cell carcinoma, Surgery",
author = "Fumihiro Ito and Hiroyuki Ozawa and Mariko Sekimizu and Yoshihiro Watanabe and Toshiki Tomita and Yorihisa Imanishi and Kaoru Ogawa",
year = "2017",
language = "English",
volume = "120",
pages = "825--832",
journal = "Journal of Otolaryngology of Japan",
issn = "0030-6622",
publisher = "Oto-Rhino-Laryngological Society of Japan Inc.",
number = "6",

}

TY - JOUR

T1 - A clinical study of pharyngeal small cell carcinoma

AU - Ito, Fumihiro

AU - Ozawa, Hiroyuki

AU - Sekimizu, Mariko

AU - Watanabe, Yoshihiro

AU - Tomita, Toshiki

AU - Imanishi, Yorihisa

AU - Ogawa, Kaoru

PY - 2017

Y1 - 2017

N2 - Extrapulmonary small cell carcinoma arising from the pharynx is rare. We have experienced 4 cases of pharyngeal small cell carcinoma. All the patients were male, and the mean age was 66 years old. The primary site was the oropharynx in 2 cases and the hypopharynx in 2 cases. All the patients initially underwent surgical resection, followed by chemotherapy or chemoradiotherapy. Three patients died because of distant metastasis. One patient is still alive without disease. Twentyfour cases of pharyngeal small cell carcinoma have been reported to date. An analysis of these 28 cases, including our 4 cases, revealed that 20 of the cases had died because of pharyngeal small cell carcinoma. Thus, pharyngeal small cell carcinoma appears to be associated with a relatively poor prognosis similar to that of pulmonary small cell carcinoma. Patients with T3/4 or metastatic diseases have an especially poor prognosis. When the primary site is resectable with minimum invasion, surgery followed by chemotherapy or chemoradiotherapy might offer a better chance of inhibiting local recurrence, compared with other strategies.

AB - Extrapulmonary small cell carcinoma arising from the pharynx is rare. We have experienced 4 cases of pharyngeal small cell carcinoma. All the patients were male, and the mean age was 66 years old. The primary site was the oropharynx in 2 cases and the hypopharynx in 2 cases. All the patients initially underwent surgical resection, followed by chemotherapy or chemoradiotherapy. Three patients died because of distant metastasis. One patient is still alive without disease. Twentyfour cases of pharyngeal small cell carcinoma have been reported to date. An analysis of these 28 cases, including our 4 cases, revealed that 20 of the cases had died because of pharyngeal small cell carcinoma. Thus, pharyngeal small cell carcinoma appears to be associated with a relatively poor prognosis similar to that of pulmonary small cell carcinoma. Patients with T3/4 or metastatic diseases have an especially poor prognosis. When the primary site is resectable with minimum invasion, surgery followed by chemotherapy or chemoradiotherapy might offer a better chance of inhibiting local recurrence, compared with other strategies.

KW - Chemoradiotherapy

KW - Pharyngeal cancer

KW - Small cell carcinoma

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85024121351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024121351&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85024121351

VL - 120

SP - 825

EP - 832

JO - Journal of Otolaryngology of Japan

JF - Journal of Otolaryngology of Japan

SN - 0030-6622

IS - 6

ER -